Pharmacokinetics and central nervous system effects of the novel dual <scp>NK₁/NK₃</scp> receptor antagonist <scp>GSK</scp>1144814 in alcohol‐intoxicated volunteers

Abstract

Administration of GSK1144814 in the presence of alcohol was generally well tolerated and not likely to produce clinically relevant additional impairments after alcohol consumption.